Unveiling Liver Micro-Distribution: NanoSIMS Imaging Reveals Critical Intracellular Distribution of Chemically

Hidenori Yasuhara1, Kenta Kadotsuji1, Kenichi Watanabe1

  • 1Preclinical Research Unit, Sumitomo Pharma Co., Ltd., Osaka, Japan.

Nucleic Acid Therapeutics
|November 28, 2025
PubMed
Summary

Antisense oligonucleotides (ASOs) show varied liver distribution based on chemical modifications. Nanoscale secondary ion mass spectrometry (NanoSIMS) imaging reveals distinct cellular uptake patterns, crucial for optimizing ASO therapies.